Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
333
-
Total 13F shares, excl. options
-
36M
-
Shares change
-
+614K
-
Total reported value, excl. options
-
$7.04B
-
Value change
-
+$117M
-
Put/Call ratio
-
5.05
-
Number of buys
-
134
-
Number of sells
-
-182
-
Price
-
$195.67
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2019
394 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2019.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 333 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36M shares
of 152M outstanding shares and own 23.63% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.78M shares), VANGUARD GROUP INC (3.56M shares), WELLINGTON MANAGEMENT GROUP LLP (1.67M shares), BROWN CAPITAL MANAGEMENT LLC (1.64M shares), BAMCO INC /NY/ (1.57M shares), Neuberger Berman Group LLC (1.4M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.35M shares), JANUS HENDERSON GROUP PLC (1.32M shares), Mairs & Power INC (1.04M shares), and Invesco Ltd. (1.02M shares).
This table shows the top 333 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.